• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $PDCO

    Patterson Companies Inc.

    Subscribe to $PDCO
    $PDCO
    Medical Specialities
    Health Care

    Patterson Companies, Inc. distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. It operates through three segments; Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritionals, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.

    IPO Year: 1992

    Exchange: NASDAQ

    Website: pattersoncompanies.com

    Peers

    $HSIC
    $PTEN

    Recent Analyst Ratings for Patterson Companies Inc.

    DatePrice TargetRatingAnalyst
    12/4/2024$23.00Neutral
    Mizuho
    2/29/2024$34.00 → $28.00Overweight → Neutral
    Piper Sandler
    2/26/2024$36.00Outperform
    Leerink Partners
    5/13/2022$36.00Outperform
    Credit Suisse
    3/3/2022$30.00 → $32.00Equal-Weight
    Morgan Stanley
    1/31/2022$30.00Equal-Weight
    Morgan Stanley
    10/1/2021$38.00Outperform
    Credit Suisse
    See more ratings

    Patterson Companies Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Mizuho initiated coverage on Patterson Companies with a new price target

      Mizuho initiated coverage of Patterson Companies with a rating of Neutral and set a new price target of $23.00

      12/4/24 7:46:30 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded Patterson Companies from Overweight to Neutral and set a new price target of $28.00 from $34.00 previously

      2/29/24 6:36:04 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • Leerink Partners initiated coverage on Patterson Companies with a new price target

      Leerink Partners initiated coverage of Patterson Companies with a rating of Outperform and set a new price target of $36.00

      2/26/24 8:10:56 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • Credit Suisse resumed coverage on Patterson Companies with a new price target

      Credit Suisse resumed coverage of Patterson Companies with a rating of Outperform and set a new price target of $36.00

      5/13/22 7:23:44 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • Morgan Stanley reiterated coverage on Patterson Companies with a new price target

      Morgan Stanley reiterated coverage of Patterson Companies with a rating of Equal-Weight and set a new price target of $32.00 from $30.00 previously

      3/3/22 9:54:43 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • Morgan Stanley initiated coverage on Patterson Companies with a new price target

      Morgan Stanley initiated coverage of Patterson Companies with a rating of Equal-Weight and set a new price target of $30.00

      1/31/22 7:31:29 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • Credit Suisse resumed coverage on Patterson Companies with a new price target

      Credit Suisse resumed coverage of Patterson Companies with a rating of Outperform and set a new price target of $38.00

      10/1/21 7:35:35 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded Patterson Companies from Neutral to Overweight and set a new price target of $44.00 from $34.00 previously

      6/17/21 6:27:10 AM ET
      $PDCO
      Medical Specialities
      Health Care

    Patterson Companies Inc. Leadership Updates

    Live Leadership Updates

    See more
    • Sterling Infrastructure Set to Join S&P SmallCap 600

      NEW YORK, April 14, 2025 /PRNewswire/ -- Sterling Infrastructure Inc. (NASD: STRL) will replace Patterson Companies Inc. (NASD: PDCO) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, April 17. Patient Square Capital is acquiring Patterson Companies in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector April 17, 2025 S&P SmallCap 600 Addition Sterling Infrastructure STRL Industrials April 17, 2025 S&P SmallCap 600 Deletion Patterson Companies PDCO Health Care Fo

      4/14/25 6:43:00 PM ET
      $PDCO
      $SPGI
      $STRL
      Medical Specialities
      Health Care
      Finance: Consumer Services
      Finance
    • Patterson Companies Announces Dental Leadership Appointment

      Kristin Dietzler Named Dental President Patterson Companies Inc. (NASDAQ:PDCO) announced the appointment of Kristin Dietzler as Patterson Dental's North American president. Dietzler brings extensive expertise in adjacent healthcare companies with a proven track record of success in optimizing results. She will report to Kevin Pohlman, chief operating officer of Patterson Companies, and she will be a member of the company's executive leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241023782217/en/Kristin Dietzler Named Patterson Dental President (Photo: Business Wire) Dietzler joins Patterson Dental with nearly 30

      10/23/24 6:00:00 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies Announces Dental Leadership Transition

      Patterson Companies, Inc. (NASDAQ:PDCO) today announced that it has initiated a search for a new leader for its Dental segment. Tim Rogan, who has served as President of Patterson Dental since 2021, has stepped down from his role, effective immediately, and agreed to serve as an advisor to the Company in the short term to facilitate a smooth transition. The Dental segment will continue to report to Chief Operating Officer, Kevin Pohlman. "Our dental business has made significant progress to further enhance our value proposition and differentiate Patterson as the partner of choice for our customers. After careful consideration, we determined that a leadership transition will best position

      5/10/24 7:00:00 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • Pure Storage Set to Join S&P MidCap 400; Patterson Companies to Join S&P SmallCap 600

      NEW YORK, Jan. 2, 2024 /PRNewswire/ -- Pure Storage Inc. (NYSE:PSTG) will replace Patterson Companies Inc. (NASD:PDCO) in the S&P MidCap 400, and Patterson Companies will replace Chico's FAS Inc. (NYSE:CHS) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 5. Sycamore Partners is acquiring Chico's FAS in a transaction expected to be completed on or about that date pending final conditions. Patterson Companies has a market capitalization that is more representative of the small-cap market space.                                Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index N

      1/2/24 6:21:00 PM ET
      $CHS
      $PDCO
      $PSTG
      $SPGI
      Clothing/Shoe/Accessory Stores
      Consumer Discretionary
      Medical Specialities
      Health Care
    • Patterson Companies Announces Leadership Transition

      Don Zurbay Appointed President and CEO Kevin Barry Appointed Interim Chief Financial Officer Reaffirms Fiscal 2023 Earnings Guidance Patterson Companies, Inc. (NASDAQ:PDCO) today announced that its Board of Directors has appointed Don Zurbay, most recently Chief Financial Officer, as President and Chief Executive Officer. Mr. Zurbay succeeds Mark Walchirk who resigned following the Board's investigation and determination that he violated company policy and demonstrated poor judgment regarding an encounter with an employee. The conduct did not relate to the company's operations or the integrity of the company's financial statements. Mr. Zurbay has also been elected to the Board. Kevin Bar

      10/13/22 9:00:00 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • Ferguson PLC Announces Non-Executive Director Appointment

      WOKINGHAM, UK / ACCESSWIRE / April 16, 2021 / Ferguson plc announces the appointment of Kelly Baker to the Board as a Non-Executive Director effective May 1, 2021.Kelly, a US citizen, has extensive human resources ("HR") and operational experience having led the people, organizational and cultural development across a number of US based, global public companies. Kelly is currently Executive Vice President ("EVP"), Chief Human Resources Officer ("CHRO") of Pentair plc (NYSE:PNR), a leading manufacturer of water products, a role she has held since December 2017. Prior to this, Kelly was EVP, CHRO at Patterson Companies Inc. (NASDAQ:PDCO), a value-added distributor serving dental and animal hea

      4/16/21 2:00:00 AM ET
      $PNR
      $FERG
      $PDCO
      $GIS
      Industrial Machinery/Components
      Industrials
      Miscellaneous
      Medical Specialities

    Patterson Companies Inc. Financials

    Live finance-specific insights

    See more
    • Patterson Companies Reports Fiscal 2025 Third Quarter Operating Results

      Third quarter reported net sales decreased 2.7 percent year-over-year to $1.57 billion, and internal sales decreased 2.4 percent. Delivered third quarter GAAP earnings of $0.35 per diluted share and adjusted earnings1 of $0.43 per diluted share; both GAAP and adjusted earnings1 were negatively impacted by the cybersecurity attack on Change Healthcare compared to the prior year. Returned $119.2 million to shareholders in the form of cash dividends and share repurchases through the first nine months of fiscal 2025. Patterson Companies, Inc. (NASDAQ:PDCO) today reported operating results for its fiscal 2025 third quarter ended January 25, 2025. "As we continue to progress toward cl

      2/26/25 4:30:00 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies Reports Fiscal 2025 Second Quarter Operating Results

      Second quarter reported net sales increased 1.3 percent year-over-year to $1.67 billion, and internal sales increased 0.6 percent. Delivered second quarter GAAP earnings of $0.30 per diluted share and adjusted earnings1 of $0.47 per diluted share; both GAAP and adjusted earnings1 were negatively impacted by the cybersecurity attack on Change Healthcare compared to the prior year. Returned $96.2 million to shareholders in the form of cash dividends and share repurchases through the first six months of fiscal 2025. Revises fiscal 2025 GAAP earnings guidance range to $1.83 to $1.93 per diluted share and adjusted earnings1 guidance range to $2.25 to $2.35 per diluted share. Company

      12/5/24 7:00:00 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies Fiscal 2025 Second Quarter Conference Call Scheduled for Thursday, December 5, 2024

      Patterson Companies (NASDAQ:PDCO) today announced that it will hold its fiscal 2025 second-quarter conference call on Thursday, December 5, 2024, at 7:30 a.m. CT (8:30 a.m. ET). The company's earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com. An audio replay of the fiscal 2025 second-quarter conference call will also be available for one week. To access the audio replay, please pre-register at https://registrations.events/direct/Q4I672812531 to receive a unique access code to access and listen to the audio playback. About Patterson Companies Inc. Pa

      11/27/24 7:19:00 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies Declares Regular Quarterly Cash Dividend

      On September 17, 2024, the Board of Directors of Patterson Companies, Inc. (NASDAQ:PDCO) declared a quarterly cash dividend of $0.26 per share. The dividend will be payable on, or about, November 1, 2024, to shareholders of record as of the close of business on October 18, 2024. About Patterson Companies Inc. Patterson Companies Inc. (NASDAQ:PDCO) connects dental and animal health customers in North America and the U.K. to the latest products, technologies, services and innovative business solutions that enable operational and professional success. Our comprehensive portfolio, distribution network and supply chain is equaled only by our dedicated, knowledgeable people who deliver unrivall

      9/17/24 4:30:00 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies Reports Fiscal 2025 First Quarter Operating Results

      First quarter reported net sales decreased 2.2 percent year-over-year to $1.54 billion, and internal sales decreased 2.8 percent. Returned $73.3 million to shareholders in first quarter of fiscal 2025 through dividends and share repurchases. Delivered first quarter GAAP earnings of $0.15 per diluted share and adjusted earnings1 of $0.24 per diluted share; both GAAP and adjusted earnings1 were negatively impacted by the cybersecurity attack on Change Healthcare compared to the prior year. Reaffirms fiscal 2025 GAAP earnings guidance range of $2.00 to $2.10 per diluted share and adjusted earnings1 guidance range of $2.33 to $2.43 per diluted share. Patterson Companies, Inc. (NASD

      8/28/24 7:00:00 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies Fiscal 2025 First Quarter Conference Call Scheduled for Wednesday, August 28, 2024

      Patterson Companies (NASDAQ:PDCO) today announced that it will hold its fiscal 2025 first-quarter conference call on Wednesday, August 28, 2024, at 7:30 a.m. CT (8:30 a.m. ET). The company's earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com. The fiscal 2025 first-quarter earnings conference call replay will be available beginning at 10 a.m. CT (11 a.m. ET) on Wednesday, August 28, 2024, through 10 p.m. CT (11 p.m. ET) on Tuesday, September 3, 2024. Interested persons may dial (800) 770-2030 and enter Conference ID 67281 when prompted. About Patterso

      8/21/24 6:02:00 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies Reports Fiscal 2024 Fourth Quarter and Year End Operating Results

      Fourth quarter reported net sales increased 0.1 percent year-over-year to $1.72 billion, and internal sales decreased 0.5 percent. Fourth quarter internal sales benefitted from strong growth in production animal as well as dental consumables growth of 3.7 percent year-over-year. Returned $327.9 million to shareholders in fiscal 2024 through dividends and share repurchases. Delivered fourth quarter GAAP earnings of $0.74 per diluted share and adjusted earnings1 of $0.82 per diluted share; both GAAP and adjusted earnings1 were negatively impacted by $0.04 per diluted share due to the cybersecurity attack on Change Healthcare. Achieved fiscal 2024 GAAP earnings of $1.98 per dilute

      6/18/24 7:00:00 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies Fiscal 2024 Fourth Quarter and Year End Conference Call Scheduled for Tuesday, June 18, 2024

      Patterson Companies (NASDAQ:PDCO) today announced that it will hold its fiscal 2024 fourth-quarter and year end conference call on Tuesday, June 18, 2024, at 7:30 a.m. CT (8:30 a.m. ET). The company's earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com. The fiscal 2024 fourth-quarter earnings conference call replay will be available beginning at 10 a.m. CT (11 a.m. ET) on Tuesday, June 18, 2024, through 10 p.m. CT (11 p.m. ET) on Tuesday, June 25, 2024. Interested persons may dial (800) 770-2030 and enter Conference ID 67281 when prompted. About Patte

      6/12/24 4:30:00 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies Declares Regular Quarterly Cash Dividend

      On June 11, 2024, the Board of Directors of Patterson Companies, Inc. (NASDAQ:PDCO) declared a quarterly cash dividend of $0.26 per share. The dividend will be payable on, or about, August 2, 2024, to shareholders of record as of the close of business on July 19, 2024. About Patterson Companies Inc. Patterson Companies Inc. (NASDAQ:PDCO) connects dental and animal health customers in North America and the U.K. to the latest products, technologies, services and innovative business solutions that enable operational and professional success. Our comprehensive portfolio, distribution network and supply chain is equaled only by our dedicated, knowledgeable people who deliver unrivalled exper

      6/11/24 4:30:00 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies Board Approves New Share Repurchase Authorization and Declares Regular Quarterly Cash Dividend

      On March 11, 2024, the Board of Directors of Patterson Companies, Inc. (NASDAQ:PDCO) approved a new share repurchase authorization for the repurchase of up to $500 million of the company's common stock through March 16, 2027, replacing a prior authorization which was expiring and under which there was $194.9 million remaining. The Board also declared a quarterly cash dividend of $0.26 per share. The dividend will be payable on, or about, May 3, 2024, to shareholders of record as of the close of business on April 19, 2024. About Patterson Companies Inc. Patterson Companies Inc. (NASDAQ:PDCO) connects dental and animal health customers in North America and the U.K. to the latest product

      3/11/24 8:04:00 PM ET
      $PDCO
      Medical Specialities
      Health Care

    Patterson Companies Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Sterling Infrastructure Set to Join S&P SmallCap 600

      NEW YORK, April 14, 2025 /PRNewswire/ -- Sterling Infrastructure Inc. (NASD: STRL) will replace Patterson Companies Inc. (NASD: PDCO) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, April 17. Patient Square Capital is acquiring Patterson Companies in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector April 17, 2025 S&P SmallCap 600 Addition Sterling Infrastructure STRL Industrials April 17, 2025 S&P SmallCap 600 Deletion Patterson Companies PDCO Health Care Fo

      4/14/25 6:43:00 PM ET
      $PDCO
      $SPGI
      $STRL
      Medical Specialities
      Health Care
      Finance: Consumer Services
      Finance
    • Patterson Companies, Inc. Shareholders Approve Acquisition by Patient Square Capital

      Patterson Companies, Inc. (NASDAQ:PDCO), a value-added specialty distributor serving the U.S. and Canadian dental supply markets and the U.S., Canadian and U.K. animal health supply markets, today announced that its shareholders approved at a special meeting the acquisition of Patterson by Patient Square Capital, a dedicated health care investment firm. Don Zurbay, Patterson's President and Chief Executive Officer, said, "I would like to express my gratitude to the Patterson shareholders for their support today, and throughout this transaction process. The Patterson team is excited about this partnership with Patient Square Capital and beginning our next chapter as a private company. We be

      4/1/25 1:00:00 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies Reports Fiscal 2025 Third Quarter Operating Results

      Third quarter reported net sales decreased 2.7 percent year-over-year to $1.57 billion, and internal sales decreased 2.4 percent. Delivered third quarter GAAP earnings of $0.35 per diluted share and adjusted earnings1 of $0.43 per diluted share; both GAAP and adjusted earnings1 were negatively impacted by the cybersecurity attack on Change Healthcare compared to the prior year. Returned $119.2 million to shareholders in the form of cash dividends and share repurchases through the first nine months of fiscal 2025. Patterson Companies, Inc. (NASDAQ:PDCO) today reported operating results for its fiscal 2025 third quarter ended January 25, 2025. "As we continue to progress toward cl

      2/26/25 4:30:00 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies Announces Expiration of "Go-Shop" Period

      Transaction Is Expected to Close in April 2025 Patterson Companies, Inc. (NASDAQ:PDCO), a leading dental and animal health distributor, today announced the expiration of the 40-day "go-shop" period under the terms of the previously announced definitive merger agreement, pursuant to which Patient Square Capital, L.P. ("Patient Square"), a dedicated health care investment firm, will acquire Patterson for $31.35 per share, in an all-cash transaction valued at approximately $4.1 billion, including the refinancing of Patterson's receivables facilities. The "go-shop" period expired at 11:59 p.m. (Central Time) on January 19, 2025. Pursuant to the merger agreement, Patterson and its representa

      1/21/25 5:00:00 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies Announces Definitive Agreement to Be Acquired by Patient Square Capital for $31.35 Per Share in Cash

      Valued at Approximately $4.1 Billion Patterson Companies, Inc. (NASDAQ:PDCO), a leading dental and animal health distributor, today announced that it has entered into a definitive agreement to be acquired by Patient Square Capital (Patient Square), a dedicated health care investment firm. Under the terms of the agreement, Patterson shareholders will receive $31.35 in cash per share, representing an approximately 49% premium to Patterson's 30 calendar day volume-weighted average price (VWAP) ending December 4, 2024 (the last trading day prior to Patterson announcing the evaluation of strategic alternatives), or a transaction value of approximately $4.1 billion, including the refinancing of

      12/11/24 7:00:00 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • Rectangle Health Collaborates with Patterson Dental to Enhance Payment Solutions for Healthcare Providers

      Patterson Approved Vendor status will pave the way for customers to securely use new payments capabilities. VALHALLA, N.Y., Dec. 10, 2024 /PRNewswire/ -- Rectangle Health, a leading provider of innovative payment solutions for healthcare providers, today announced integrations with Patterson Dental Supply, Inc., a subsidiary of Patterson Companies, Inc. (NASDAQ:PDCO). The approved integrations with Patterson Dental's industry-leading practice management software solutions – Dolphin Management, Fuse, and Eaglesoft – aim to streamline payment processes and enhance the financial experience for dental practices and their patients.

      12/10/24 9:00:00 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies Reports Fiscal 2025 Second Quarter Operating Results

      Second quarter reported net sales increased 1.3 percent year-over-year to $1.67 billion, and internal sales increased 0.6 percent. Delivered second quarter GAAP earnings of $0.30 per diluted share and adjusted earnings1 of $0.47 per diluted share; both GAAP and adjusted earnings1 were negatively impacted by the cybersecurity attack on Change Healthcare compared to the prior year. Returned $96.2 million to shareholders in the form of cash dividends and share repurchases through the first six months of fiscal 2025. Revises fiscal 2025 GAAP earnings guidance range to $1.83 to $1.93 per diluted share and adjusted earnings1 guidance range to $2.25 to $2.35 per diluted share. Company

      12/5/24 7:00:00 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies Fiscal 2025 Second Quarter Conference Call Scheduled for Thursday, December 5, 2024

      Patterson Companies (NASDAQ:PDCO) today announced that it will hold its fiscal 2025 second-quarter conference call on Thursday, December 5, 2024, at 7:30 a.m. CT (8:30 a.m. ET). The company's earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com. An audio replay of the fiscal 2025 second-quarter conference call will also be available for one week. To access the audio replay, please pre-register at https://registrations.events/direct/Q4I672812531 to receive a unique access code to access and listen to the audio playback. About Patterson Companies Inc. Pa

      11/27/24 7:19:00 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Dental Extends Strategic Relationship With PDS Health

      Patterson Dental remains the premier distributor for PDS Health's network of over 1,000 supported practices across the United States, providing equipment, services, technology and more Patterson Dental Supply, Inc., a subsidiary of Patterson Companies, Inc. (NASDAQ:PDCO), today announced an agreement in principle between Patterson and PDS Health, a leading dental and medical support organization formerly known as Pacific Dental Services, to extend their strategic relationship through the end of 2027. The extension allows Patterson to continue as the premier distributor for all merchandise, services, technology and core equipment across PDS Health's network of more than 1,000 supported pra

      11/13/24 7:00:00 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies Announces Dental Leadership Appointment

      Kristin Dietzler Named Dental President Patterson Companies Inc. (NASDAQ:PDCO) announced the appointment of Kristin Dietzler as Patterson Dental's North American president. Dietzler brings extensive expertise in adjacent healthcare companies with a proven track record of success in optimizing results. She will report to Kevin Pohlman, chief operating officer of Patterson Companies, and she will be a member of the company's executive leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241023782217/en/Kristin Dietzler Named Patterson Dental President (Photo: Business Wire) Dietzler joins Patterson Dental with nearly 30

      10/23/24 6:00:00 AM ET
      $PDCO
      Medical Specialities
      Health Care

    Patterson Companies Inc. SEC Filings

    See more
    • SEC Form 15-12G filed by Patterson Companies Inc.

      15-12G - PATTERSON COMPANIES, INC. (0000891024) (Filer)

      4/28/25 10:30:38 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • SEC Form 8-K filed by Patterson Companies Inc.

      8-K - PATTERSON COMPANIES, INC. (0000891024) (Filer)

      4/22/25 9:00:17 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • SEC Form S-8 POS filed by Patterson Companies Inc.

      S-8 POS - PATTERSON COMPANIES, INC. (0000891024) (Filer)

      4/17/25 9:23:38 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • SEC Form S-8 POS filed by Patterson Companies Inc.

      S-8 POS - PATTERSON COMPANIES, INC. (0000891024) (Filer)

      4/17/25 9:20:31 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • SEC Form S-8 POS filed by Patterson Companies Inc.

      S-8 POS - PATTERSON COMPANIES, INC. (0000891024) (Filer)

      4/17/25 9:17:41 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • SEC Form S-8 POS filed by Patterson Companies Inc.

      S-8 POS - PATTERSON COMPANIES, INC. (0000891024) (Filer)

      4/17/25 9:14:44 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • SEC Form S-8 POS filed by Patterson Companies Inc.

      S-8 POS - PATTERSON COMPANIES, INC. (0000891024) (Filer)

      4/17/25 9:11:58 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • Patterson Companies Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update

      8-K - PATTERSON COMPANIES, INC. (0000891024) (Filer)

      4/17/25 9:06:17 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • SEC Form 8-K filed by Patterson Companies Inc.

      8-K - PATTERSON COMPANIES, INC. (0000891024) (Filer)

      4/1/25 1:05:28 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • SEC Form DEFA14A filed by Patterson Companies Inc.

      DEFA14A - PATTERSON COMPANIES, INC. (0000891024) (Filer)

      3/24/25 8:05:09 AM ET
      $PDCO
      Medical Specialities
      Health Care

    Patterson Companies Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Tomczik Pamela J returned 7,820 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)

      4/17/25 2:15:41 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • Director Schrimsher Neil A returned 48,788 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)

      4/17/25 2:08:45 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • Director Mckoy Philip returned 18,114 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)

      4/17/25 2:06:32 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • Director Frenzel Robert returned 38,242 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)

      4/17/25 2:04:46 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • Director Feragen Jody H returned 56,145 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)

      4/17/25 1:58:59 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • Director Buck John D returned 92,869 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)

      4/17/25 1:50:21 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • Director Blanco Alex N returned 41,300 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)

      4/17/25 1:46:27 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • Director Agarwal Meenu returned 12,788 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)

      4/17/25 1:44:23 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • President & CEO Zurbay Donald was granted 175,449 shares and returned 399,428 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)

      4/17/25 1:30:30 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • Chief Operating Officer Pohlman Kevin M was granted 59,810 shares and returned 219,030 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)

      4/17/25 1:27:03 PM ET
      $PDCO
      Medical Specialities
      Health Care

    Patterson Companies Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Patterson Companies Inc. (Amendment)

      SC 13G/A - PATTERSON COMPANIES, INC. (0000891024) (Subject)

      2/13/24 5:12:03 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Patterson Companies Inc. (Amendment)

      SC 13G/A - PATTERSON COMPANIES, INC. (0000891024) (Subject)

      12/8/23 4:16:31 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Patterson Companies Inc. (Amendment)

      SC 13G/A - PATTERSON COMPANIES, INC. (0000891024) (Subject)

      2/14/23 12:37:55 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Patterson Companies Inc. (Amendment)

      SC 13G/A - PATTERSON COMPANIES, INC. (0000891024) (Subject)

      9/12/22 2:07:45 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Patterson Companies Inc. (Amendment)

      SC 13G/A - PATTERSON COMPANIES, INC. (0000891024) (Subject)

      2/14/22 2:34:19 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Patterson Companies Inc. (Amendment)

      SC 13G/A - PATTERSON COMPANIES, INC. (0000891024) (Subject)

      2/10/22 8:32:46 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Patterson Companies Inc. (Amendment)

      SC 13G/A - PATTERSON COMPANIES, INC. (0000891024) (Subject)

      2/9/22 10:24:56 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed

      SC 13G/A - PATTERSON COMPANIES, INC. (0000891024) (Subject)

      2/16/21 12:23:39 PM ET
      $PDCO
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed

      SC 13G/A - PATTERSON COMPANIES, INC. (0000891024) (Subject)

      2/10/21 11:40:08 AM ET
      $PDCO
      Medical Specialities
      Health Care
    • SEC Form SC 13G filed

      SC 13G - PATTERSON COMPANIES, INC. (0000891024) (Subject)

      2/8/21 10:29:25 AM ET
      $PDCO
      Medical Specialities
      Health Care